Notably, MEX3A inhibition not only suppresses proliferative capacity of tumor cells (Figure 8F, S12H-I), but also renders tumor cell-state conversion from stemness to differentiation, evidenced by reduction of CD44 and upregulation of E-cadherin (Figure 8G). The gene discussed is CD44; the disease is neoplasm.